{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:55:47Z","timestamp":1774122947780,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1233,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.jcf.2009.12.002","type":"journal-article","created":{"date-parts":[[2010,2,5]],"date-time":"2010-02-05T09:18:41Z","timestamp":1265361521000},"page":"124-129","source":"Crossref","is-referenced-by-count":18,"title":["What is the best method for measuring renal function in adults and children with cystic fibrosis?"],"prefix":"10.1016","volume":"9","author":[{"given":"Natalie","family":"Soulsby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh","family":"Greville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kingsley","family":"Coulthard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Doecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt 2","key":"10.1016\/j.jcf.2009.12.002_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1258\/0004563021901847","article-title":"Cystatin C","volume":"39","author":"Newman","year":"2002","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"10.1016\/j.jcf.2009.12.002_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1515\/CCLM.1999.064","article-title":"Serum cystatin C as an endogenous marker of the renal function\u2014a review","volume":"37","author":"Randers","year":"1999","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1016\/j.jcf.2009.12.002_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.jcf.2009.12.002_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine","volume":"58","author":"Schwartz","year":"1976","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.jcf.2009.12.002_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcf.2009.12.002_bib6","article-title":"Measurement and estimation of GFR in children and adolescents","author":"Work","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.jcf.2009.12.002_bib7","first-page":"424","article-title":"Comparison of methods for calculating glomerular filtration rate: technetium-99m-DTPA scintigraphic analysis, protein-free and whole-plasma clearance of technetium-99m-DTPA and iodine-125-iothalamate clearance","volume":"31","author":"Goates","year":"1990","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.jcf.2009.12.002_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1056\/NEJM199607183350307","article-title":"Management of pulmonary disease in patients with cystic fibrosis","volume":"335","author":"Ramsey","year":"1996","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcf.2009.12.002_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/AAC.41.1.95","article-title":"Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model","volume":"41","author":"den Hollander JG","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jcf.2009.12.002_bib10","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/clinids\/24.5.796","article-title":"A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides","volume":"24","author":"Ali MZ","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jcf.2009.12.002_bib11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1148\/94.3.679","article-title":"Technetium-99m DTPA: a new radiopharmaceutical for brain and kidney scanning","volume":"94","author":"Hauser","year":"1970","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.jcf.2009.12.002_bib12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1464-5491.2007.02112.x","article-title":"The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes","volume":"24","author":"Macisaac","year":"2007","journal-title":"Diabet Med"},{"issue":"6 Pt 1","key":"10.1016\/j.jcf.2009.12.002_bib13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/clinchem\/45.6.882","article-title":"Necessary sample size for method comparison studies based on regression analysis","volume":"45","author":"Linnet","year":"1999","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.jcf.2009.12.002_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1191\/096228099673819272","article-title":"Measuring agreement in method comparison studies","volume":"8","author":"Bland JM","year":"1999","journal-title":"Stat Methods Med Res"},{"issue":"4","key":"10.1016\/j.jcf.2009.12.002_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"39","author":"Zweig MH","year":"1993","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.jcf.2009.12.002_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcf.2008.07.004","article-title":"GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis","volume":"8","author":"Beringer PM","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2009.12.002_bib17","series-title":"Renal function monitoring for IV tobramycin and colistin in patients with Cystic Fibrosis","year":"2006"},{"issue":"4","key":"10.1016\/j.jcf.2009.12.002_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijantimicag.2005.05.004","article-title":"Bicompartmental kinetics of tobramycin analysed with a wide range of covariates","volume":"26","author":"Inclan","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jcf.2009.12.002_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jac\/42.1.103","article-title":"The pharmacokinetics and toxicity of once-daily tobramycin therapy in children with cystic fibrosis","volume":"42","author":"Bragonier","year":"1998","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jcf.2009.12.002_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2125.1989.tb05431.x","article-title":"Population pharmacokinetics of tobramycin","volume":"28","author":"Aarons","year":"1989","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.jcf.2009.12.002_bib21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/jac\/dkf168","article-title":"Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosis","volume":"50","author":"Aminimanizani","year":"2002","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199310000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199310000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T03:28:40Z","timestamp":1685417320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199310000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1569199310000020"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2009.12.002","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}